All In Biotech

Free tool

FAERS Monitor: Actemra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125276 or its brand name (Actemra, Tocilizumab). Reports on generic versions are filed under their own applications.

Reports

111,624

Serious

87,343

78% of reports

Hospitalization

29,430

Death reported

12,577

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective35,396
  • rheumatoid arthritis22,842
  • off label use20,484
  • pain20,190
  • arthralgia17,214
  • joint swelling16,308
  • fatigue15,435
  • rash13,831
  • drug intolerance13,220
  • contraindicated product administered12,254
  • arthropathy11,001
  • alopecia10,797
  • abdominal discomfort10,661
  • synovitis10,654
  • swelling10,553

Reports by year received

View as table
YearReports
200611
20074
20083
200916
2010821
20111,172
20121,880
20132,207
20141,912
20152,597
20164,062
20177,492
20187,919
20199,719
202016,679
202112,628
202211,988
20239,186
202410,238
20256,917
20264,173

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,942,535 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
synovitisSignal10,654270.3262.51,172,010
contraindicated product administeredSignal12,254127.3124.6916,246
rheumatoid arthritisSignal22,84247.246.6829,696
arthropathySignal11,00146.245.3391,584
drug intoleranceSignal13,22029.729.2318,079
joint swellingSignal16,30829.328.8387,411
swellingSignal10,55323.823.4205,589
abdominal discomfortSignal10,66112.712.5108,662
alopeciaSignal10,79710.910.792,642
arthralgiaSignal17,2148.18.0104,673
painSignal20,1906.46.391,043
rashSignal13,8316.16.058,864
drug ineffectiveSignal35,3965.25.1123,690
off label useSignal20,4844.54.456,612
fatigueSignal15,4353.83.732,278

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.